Skip to content
Avada Landing Product
  • Global Development Token
    • [Home] About Global Development Token
    • Key Technology
    • Business Plan & Progress
  • About Us
    • About Us
    • Vision & Mission
    • Teams & Partners
    • History
    • Community
    • FAQs
    • Pricact Policy
  • How to Participate
  • News
  • Contact
  • Global Development Token
    • [Home] About Global Development Token
    • Key Technology
    • Business Plan & Progress
  • About Us
    • About Us
    • Vision & Mission
    • Teams & Partners
    • History
    • Community
    • FAQs
    • Pricact Policy
  • How to Participate
  • News
  • Contact
  • Global Development Token
    • [Home] About Global Development Token
    • Key Technology
    • Business Plan & Progress
  • About Us
    • About Us
    • Vision & Mission
    • Teams & Partners
    • History
    • Community
    • FAQs
    • Pricact Policy
  • How to Participate
  • News
  • Contact
Buy GDT
Newsgdtadmin2025-08-13T15:42:27+09:00
  • All
  • Blog
  • Press Release
  • Shiga University of Medical Science and KIYAN PHARMA Collaborate on 5-ALA for Diabetes Cure

    Press ReleaseApril 11th, 2024

    July 2024 — Professor Hideto Kojima of Shiga University of Medical Science, together with members of his research team, visited the KIYAN PHARMA Co., Ltd. manufacturing facility in Fukuroi, Japan....

  • Strengthening Partnerships and Preparing for Business in Palau

    BlogMarch 8th, 2024

    During our recent visit to Palau, we had the honor of meeting with the President of Palau and the Governor of Koror State. These discussions reaffirmed the strong relationship between...

Previous23

News / PressRelease

  • Presentation at Japan Innovation Campus on Diabetes Cure and Biozipcode Technology

    July 31st, 2024Press Release
  • Professor Hideto Kojima Presents Biozipcode Research at International Gene Therapy Conference

    July 30th, 2024Press Release
  • Presentation at ENDO 2024 — “Diabetes Stem Cells: A Common Target for Abnormal Insulin Secretion and Insulin Resistance”

    July 1st, 2024Press Release
  • Discovery of “Diabetes Stem Cells” and Complete Remission Achieved Through Their Elimination — Presentation at JDS 2024

    May 19th, 2024Press Release
  • Shiga University of Medical Science and KIYAN PHARMA Collaborate on 5-ALA for Diabetes Cure

    April 11th, 2024Press Release
  • Strengthening Partnerships and Preparing for Business in Palau

    March 8th, 2024Blog
More News / PressRelease

Global Development Token Official Portal

Global Development Token (GDT) is issued by Auring Inc. (BVI) and operated by the Biozipcode Group, advancing curative diabetes research, medical tourism, and global healthcare innovation.

  • Global Development Token

  • How to Participate

  • Key Technology

  • Buy 5-ALA
  • About Us

  • Vision and Mission

  • Teams & Partners

  • History

  • Community

  • News / Press Release
  • Contact
  • Frequently Asked Questions
  • Privacy Policy

© 2023 – 2025 Global Development Token All Rights Reserved. | Powered by Studio Makyu Co., Ltd. & Biozipcode Group.

Page load link
Go to Top